Tag #Medicine Supply

Showing 1 to 4 of 4 results

hu.euronews.com

🌐 85% Global Worthiness

Sep 23, 22:22

EU Drug Shortages Reach Critical Levels in 2024

A new European Court of Auditors report reveals critical shortages of 136 medicines in the EU between 2022 and October 2024, impacting 21 of the 27 member states, with the most significant shortages in Belgium, Spain, and France.

EU Drug Shortages Reach Critical Levels in 2024

A new European Court of Auditors report reveals critical shortages of 136 medicines in the EU between 2022 and October 2024, impacting 21 of the 27 member states, with the most significant shortages in Belgium, Spain, and France.

Progress

8% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What factors contributed to the widespread medicine shortages across the EU?

The shortages stem from multiple factors including increased demand, production delays, capacity issues, and rising energy costs. The report also cites low pricing in national procurement procedures as adding pressure. High production costs in the EU (20-40% higher than in Asia) contribute, as the EU relies on Asia for 70% of its pharmaceutical ingredients and 79% of precursors.

gr.euronews.com

🌐 85% Global Worthiness

Mar 12, 10:11

EU Proposes "Buy European" Mechanism to Tackle Critical Medicine Shortages

The EU proposed a new critical medicines act to address drug shortages, including a "Buy European" mechanism prioritizing supply security over price in public procurement, and a coordinated supply system for medicines of common interest, impacting supply chain resilience and access to essential drug...

EU Proposes "Buy European" Mechanism to Tackle Critical Medicine Shortages

The EU proposed a new critical medicines act to address drug shortages, including a "Buy European" mechanism prioritizing supply security over price in public procurement, and a coordinated supply system for medicines of common interest, impacting supply chain resilience and access to essential drug...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key measures proposed in the "Buy European" initiative, and what are its potential limitations?

This proposal responds to significant drug shortages in the EU, particularly for essential medicines like antibiotics and insulin. The EU's heavy reliance on foreign suppliers for active pharmaceutical ingredients (APIs) and disruptions in exports have highlighted vulnerabilities. The "Buy European" approach aims to boost domestic production and diversify supply chains.

fr.euronews.com

🌐 85% Global Worthiness

Mar 15, 16:12

EU's Critical Medicines Act: "Buy European" Policy and Funding Concerns

The European Commission's proposed Critical Medicines Act aims to improve essential medicine supply within the EU, using a "Buy European" principle and increased domestic production but facing limited funding (€83 million for 2026-2027) and a lack of emergency stockpile coordination.

EU's Critical Medicines Act: "Buy European" Policy and Funding Concerns

The European Commission's proposed Critical Medicines Act aims to improve essential medicine supply within the EU, using a "Buy European" principle and increased domestic production but facing limited funding (€83 million for 2026-2027) and a lack of emergency stockpile coordination.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the proposed Critical Medicines Act address the current shortage of essential medicines within the EU, and what are the potential drawbacks of its approach?

The "Buy European" approach, while aiming to improve supply security, risks protectionism, mirroring China's policies that the EU criticized. Increased European production is encouraged, but not mandated within the EU; collaboration with neighboring countries is planned. The lack of a coordinated EU-wide emergency stockpile is a significant omission.

ru.euronews.com

🌐 85% Global Worthiness

Jan 22, 22:10

EU Excess Mortality Falls Despite Persistent Healthcare System Challenges

Excess mortality in the EU decreased to 5% in November 2024, down from 22,000 deaths compared to November 2023, despite ongoing healthcare system challenges including staff shortages and medicine supply issues; the EU's Essential Medicines Act is delayed.

EU Excess Mortality Falls Despite Persistent Healthcare System Challenges

Excess mortality in the EU decreased to 5% in November 2024, down from 22,000 deaths compared to November 2023, despite ongoing healthcare system challenges including staff shortages and medicine supply issues; the EU's Essential Medicines Act is delayed.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How have the Covid-19 pandemic and persistent healthcare worker shortages impacted the EU's medicine supply chain?

The decrease in excess mortality is set against a backdrop of significant healthcare worker strikes across Europe due to staff shortages and low pay. Data reveals that in 2022 and 2023, 20 EU countries reported physician shortages and 15 reported nurse shortages, highlighting systemic issues. The Covid-19 pandemic further exposed weaknesses, with 31 essential medicines currently in short supply.

Showing 1 to 4 of 4 results